Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arteris, Inc.AIP · Entity 2399 | Director | August 28, 2026 | September 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arteris, Inc.
Report date August 28, 2026 · Filed September 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,571 |
Ending reported balance
After 2026-09-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-28 · Exercise / conversion · Acquired 5,000 · Balance 47,571 Row 2 · 2026-09-01 · Gift · Disposed 5,000 · Balance 42,571 F1: The reporting person transferred shares of the Issuer's common stock to The Cantwell Living Trust, for which the reporting person serves as trustee, for no consideration. |
| Common StockSEC Table I · non-derivative | IndirectThe Cantwell Living Trust | 194,698 |
Reported balance
After 2026-09-01 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-01 · Gift · Acquired 5,000 · Balance 194,698 F2: The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.60 · Expires 2030-04-22 | Direct | 70,000 |
Reported balance
After 2026-08-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-08-28 · Exercise / conversion · Disposed 5,000 · Balance 70,000 F3: Non-qualified stock options, vesting in 36 equal monthly installments of 1/36th each, beginning on May 23, 2020. |
| Common StockSEC Table I · non-derivative | IndirectBy: Decathlon Capital Management 401K Plan FBO Wayne Cantwell | 38,761 |
Reported balance
Holding disclosure · report date 2026-08-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 38,761 |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person transferred shares of the Issuer's common stock to The Cantwell Living Trust, for which the reporting person serves as trustee, for no consideration.
F2: The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee.
F3: Non-qualified stock options, vesting in 36 equal monthly installments of 1/36th each, beginning on May 23, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 1, 2026 22:43 UTC | Arteris, Inc. AIP · Entity 2399 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001888679-26-000003 · primarydocument.xml · nonDerivative · entry 3 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Cantwell Living Trust Disclosed balance after: 194,698 F2 · ownership.nature: The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| September 01, 2026 Filed Sep 1, 2026 22:43 UTC | Arteris, Inc. AIP · Entity 2399 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001888679-26-000003 · primarydocument.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,571 F1 · kind: The reporting person transferred shares of the Issuer's common stock to The Cantwell Living Trust, for which the reporting person serves as trustee, for no consideration. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 22:43 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001888679-26-000003 · primarydocument.xml · derivative · entry 5 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 5,000 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Non-qualified stock options, vesting in 36 equal monthly installments of 1/36th each, beginning on May 23, 2020. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 22:43 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionCommon Stock | 5,000 | $0.60 | $3,000.00 |
DisclosureSEC source: 0001888679-26-000003 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 22:59 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 7,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001888679-26-000002 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,571 F1 · shares: Includes 7,839 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89. F2 · shares: The Reporting Person elected to defer the receipt of shares. Read SEC document |
| May 26, 2026 Filed May 27, 2026 23:26 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 38,500 | $37.23 | $1,433,166.35 |
DisclosureSEC source: 0001888679-26-000001 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Cantwell Living Trust Disclosed balance after: 189,698 F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.79 to $37.55 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 23:26 UTC | Arteris, Inc. AIP · Entity 2399 | GiftCommon Stock | 228,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-006106 · primarydocument.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Cantwell Living Trust Disclosed balance after: 228,198 F2 · ownership.nature: The shares are held by The Cantwell Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 23:26 UTC | Arteris, Inc. AIP · Entity 2399 | GiftCommon Stock | 228,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-006106 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,732 F1 · kind: The shares are transferred to The Cantwell Living Trust for which the reporting person serves as trustee. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 22:17 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 34,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004517 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,930 F1 · shares: Includes 34,732 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · shares: The reporting person elected to defer the receipt of shares. Read SEC document |
| January 03, 2025 Filed Jan 6, 2025 22:17 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 5,000 | $12.08 | $60,400.00 |
DisclosureSEC source: 0001562180-25-000197 · primarydocument.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,198 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 7, 2024. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:17 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 5,000 | $11.01 | $55,029.00 |
DisclosureSEC source: 0001562180-25-000197 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 233,198 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 7, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.04 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 22:08 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 2,600 | $10.03 | $26,077.22 |
DisclosureSEC source: 0001562180-24-008399 · primarydocument.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,198 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 7, 2024. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.09 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:08 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 2,400 | $10.01 | $24,016.08 |
DisclosureSEC source: 0001562180-24-008399 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 240,798 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 7, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.04 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:49 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 15,000 | $6.95 | $104,200.50 |
DisclosureSEC source: 0001562180-24-006756 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,198 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on June 7, 2024. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.73 to $7.28 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 21:42 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 32,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004760 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,198 F1 · shares: Includes 32,145 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 32,145 restricted stock units. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 21:29 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 570 | $8.00 | $4,560.29 |
DisclosureSEC source: 0001562180-23-005917 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,053 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 10, 2023. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.01 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 48,378 restricted stock units. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:25 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 17,359 | $7.33 | $127,319.59 |
DisclosureSEC source: 0001562180-23-005106 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,623 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.85 to $7.53 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 48,378 restricted stock units. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:06 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 48,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004985 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,982 F1 · shares: Includes 48,378 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:00 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 12,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004316 · primarydocument.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,604 F1 · shares: Fully vested restricted stock. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 11:43 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 4,266 | $7.78 | $33,169.43 |
DisclosureSEC source: 0001567619-22-013219 · doc1.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,559 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.98 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 00:34 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 158 | $7.27 | $1,148.66 |
DisclosureSEC source: 0001567619-22-012926 · doc1.xml · nonDerivative · entry 3 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,833 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 00:34 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 17,192 | $7.10 | $121,990.99 |
DisclosureSEC source: 0001567619-22-012926 · doc1.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,991 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.90 to $7.26 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 22:10 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 21,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-013010 · doc1.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,825 F1 · shares: Represents restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 00:34 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 25,150 | $7.19 | $180,916.53 |
DisclosureSEC source: 0001567619-22-012926 · doc1.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,183 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.75 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2021 Filed Oct 30, 2021 00:39 UTC | Arteris, Inc. AIP · Entity 2399 | ConversionSeries A Preferred Stock · Derivative | 38,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · derivative · entry 4 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Crescendo Ventures 401K Profit Sharing Plan FBO Wayne Cantwell Disclosed balance after: 38,760 Underlying: Common Stock · 38,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 29, 2021 Filed Oct 30, 2021 00:39 UTC | Arteris, Inc. AIP · Entity 2399 | PurchaseCommon Stock | 1 | $18.75 | $18.75 |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Crescendo Ventures 401K Profit Sharing Plan FBO Wayne Cantwell Disclosed balance after: 38,761 Read SEC document |
| October 29, 2021 Filed Oct 30, 2021 00:39 UTC | Arteris, Inc. AIP · Entity 2399 | ConversionCommon Stock | 38,760 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Crescendo Ventures 401K Profit Sharing Plan FBO Wayne Cantwell Disclosed balance after: 38,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 26, 2021 Filed Oct 30, 2021 00:39 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · nonDerivative · entry 3 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,333 F2 · shares: Includes 8,333 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F3 · balance_after: Includes 58,333 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.